Peptide–drug conjugates (PDCs) represent an important class of therapeutic agents that
combine one or more drug molecules with a short peptide through a biodegradable linker …

Covalent modification of therapeutic compounds is a clinically proven strategy to devise
prodrugs with enhanced treatment efficacies. This prodrug strategy relies on the modified …

The design of novel cancer drug nanocarriers is critical in the framework of cancer
therapeutics. Nanomaterials are gaining increased interest as cancer drug delivery systems …

In bionanotechnology, the field of creating functional materials consisting of bio-inspired
molecules, the function and shape of a nanostructure only appear through the assembly of …

High‐performance polymers have proliferated in modern society across a variety of
industries because of their low density, good chemical stability, and superior mechanical …

Biomolecular self‐assembly of hierarchical materials is a precise and adaptable bottom‐up
approach to synthesizing across scales with considerable energy, health, environment …

Peptide‐drug conjugates are prodrugs that have the advantages of precise molecular
structure and the direct exploitation of tumor‐homing, penetration or the cellular uptake …

Peptide–drug conjugates that self-assemble into supramolecular nanomaterials have
promise for uses in drug delivery. These discrete molecular species offer high and precise …

π–π stacking interaction is an attractive interaction that involves aromatic groups containing
π-conjugated domains. It is a promising strategy for stabilizing folded structures with …

This review describes recent progress in the area of molecular simulations of peptide
assemblies, including peptide-amphiphiles and drug-amphiphiles. The ability to predict the …